OFATUMUMAB

OFATUMUMAB was reported 33640 times

OFATUMUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 B SYMPTOMS 10 0.3846
1 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE IV 10 0.2222
2 MULTIPLE SCLEROSIS PSEUDO RELAPSE 70 0.2065
3 CD19 LYMPHOCYTES DECREASED 21 0.1615
4 AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT 14 0.1573
5 EXPANDED DISABILITY STATUS SCALE 10 0.1333
6 NEUROPATHIC MUSCULAR ATROPHY 12 0.1224
7 EXPANDED DISABILITY STATUS SCALE SCORE INCREASED 112 0.0897
8 RELAPSING MULTIPLE SCLEROSIS 24 0.0795
9 BLOOD IMMUNOGLOBULIN M DECREASED 76 0.0758
10 BAND SENSATION 94 0.0741
11 B-LYMPHOCYTE COUNT DECREASED 96 0.0705
12 INJECTION RELATED REACTION 104 0.0630
13 RELAPSING-REMITTING MULTIPLE SCLEROSIS 52 0.0602
14 HEMIHYPOAESTHESIA 21 0.0598
15 JC POLYOMAVIRUS TEST POSITIVE 49 0.0418
16 BLOOD IMMUNOGLOBULIN G DECREASED 101 0.0407
17 ASPERGILLUS INFECTION 262 0.0399
18 B-CELL APLASIA 10 0.0388
19 BLOOD IMMUNOGLOBULIN A DECREASED 25 0.0384
20 PRODUCT TEMPERATURE EXCURSION ISSUE 186 0.0362
21 INFLUENZA LIKE ILLNESS 2934 0.0356
22 IMMUNOGLOBULINS DECREASED 44 0.0320
23 MULTIPLE SCLEROSIS 1516 0.0317
24 CHILLS 3506 0.0299
25 MAGNETIC RESONANCE IMAGING ABNORMAL 35 0.0293
26 ELECTRIC SHOCK SENSATION 82 0.0293
27 TEMPERATURE INTOLERANCE 280 0.0271
28 MULTIPLE SCLEROSIS RELAPSE 1741 0.0254
29 PROGRESSIVE MULTIPLE SCLEROSIS 29 0.0251
30 DELIVERY 16 0.0243
31 OPTIC NEURITIS 212 0.0233
32 PRODUCT SUPPLY ISSUE 161 0.0225
33 HEAT EXHAUSTION 18 0.0223
34 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 42 0.0223
35 CAMPYLOBACTER INFECTION 18 0.0217
36 DRUG EFFECT LESS THAN EXPECTED 321 0.0216
37 CYTOPENIA 264 0.0215
38 T-LYMPHOCYTE COUNT DECREASED 14 0.0205
39 BRAIN FOG 310 0.0198
40 THYROXINE FREE DECREASED 11 0.0195
41 NORMAL NEWBORN 102 0.0187
42 OPHTHALMIC MIGRAINE 13 0.0187
43 FEELING OF BODY TEMPERATURE CHANGE 109 0.0186
44 JC VIRUS INFECTION 28 0.0175
45 MYELITIS 25 0.0161
46 LOWER RESPIRATORY TRACT INFECTION 728 0.0160
47 CENTRAL NERVOUS SYSTEM LESION 218 0.0158
48 MATERNAL EXPOSURE TIMING UNSPECIFIED 59 0.0157
49 PERONEAL NERVE PALSY 89 0.0156
50 ANOSOGNOSIA 12 0.0156
51 INJECTION SITE DISCHARGE 82 0.0152
52 INCORRECT DOSE ADMINISTERED BY DEVICE 385 0.0147
53 LIMB DISCOMFORT 450 0.0145
54 HYPOGAMMAGLOBULINAEMIA 95 0.0144
55 DECREASED IMMUNE RESPONSIVENESS 138 0.0140
56 PARAPARESIS 25 0.0140
57 INJECTION SITE HYPOAESTHESIA 20 0.0140
58 MENTAL FATIGUE 20 0.0133
59 MUSCLE SPASTICITY 164 0.0133
60 HEMIANOPIA 13 0.0131
61 BODY TEMPERATURE ABNORMAL 24 0.0130
62 ENTEROCOLITIS INFECTIOUS 12 0.0130
63 BLADDER DYSFUNCTION 13 0.0126
64 PRODUCT DISTRIBUTION ISSUE 116 0.0125
65 SARS-COV-2 TEST POSITIVE 165 0.0125
66 CLUMSINESS 33 0.0121
67 FEELING COLD 320 0.0115
68 CONCOMITANT DISEASE AGGRAVATED 67 0.0108
69 LYMPHOCYTE COUNT ABNORMAL 12 0.0107
70 EXPOSURE TO SARS-COV-2 18 0.0106
71 HEMIPARESIS 179 0.0106
72 PYREXIA 3632 0.0105
73 TRIGEMINAL NEURALGIA 42 0.0104
74 GROIN ABSCESS 12 0.0102
75 LYMPHOCYTE COUNT DECREASED 176 0.0099
76 NEUTROPENIC SEPSIS 71 0.0099
77 EPSTEIN-BARR VIRAEMIA 11 0.0099
78 PARESIS 22 0.0099
79 NEURALGIA 235 0.0097
80 DEVICE DEFECTIVE 167 0.0096
81 BLADDER DISCOMFORT 12 0.0096
82 VULVOVAGINAL CANDIDIASIS 13 0.0096
83 DIPLEGIA 19 0.0096
84 PERTUSSIS 10 0.0096
85 THERAPEUTIC RESPONSE SHORTENED 315 0.0095
86 HYPOAESTHESIA 1411 0.0094
87 LOWER RESPIRATORY TRACT CONGESTION 16 0.0094
88 OPTIC NERVE DISORDER 15 0.0094
89 FINE MOTOR SKILL DYSFUNCTION 27 0.0093
90 DEVICE DISPENSING ERROR 11 0.0093
91 CHRONIC LYMPHOCYTIC LEUKAEMIA 44 0.0093
92 LYMPH NODE PAIN 17 0.0091
93 SLUGGISHNESS 93 0.0091
94 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 75 0.0091
95 DEMYELINATION 37 0.0090
96 ACCIDENTAL EXPOSURE TO PRODUCT 921 0.0089
97 MOTION SICKNESS 17 0.0088
98 SENSORY LOSS 71 0.0088
99 RESPIRATORY SYMPTOM 25 0.0088
100 BALANCE DISORDER 751 0.0087
101 COVID-19 1523 0.0087
102 INFECTION SUSCEPTIBILITY INCREASED 19 0.0087
103 DEVICE MALFUNCTION 607 0.0086
104 INJECTION SITE PARAESTHESIA 13 0.0085
105 GAIT INABILITY 282 0.0084
106 IMMUNOSUPPRESSION 74 0.0084
107 NOROVIRUS INFECTION 12 0.0083
108 NEEDLE ISSUE 242 0.0083
109 ILLNESS 854 0.0083
110 MONOPLEGIA 36 0.0083
111 NEUROGENIC BLADDER 17 0.0080
112 FEBRILE NEUTROPENIA 534 0.0080
113 PELVIC INFLAMMATORY DISEASE 12 0.0080
114 MUSCLE FATIGUE 34 0.0080
115 MENINGITIS VIRAL 11 0.0080
116 ATYPICAL PNEUMONIA 24 0.0080
117 PARALYSIS 113 0.0079
118 PAPILLOMA VIRAL INFECTION 13 0.0079
119 MUSCULAR WEAKNESS 887 0.0078
120 RHINORRHOEA 503 0.0078
121 MUSCLE TIGHTNESS 126 0.0078
122 MONOPARESIS 14 0.0077
123 HANGOVER 27 0.0077
124 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 131 0.0076
125 GAIT DISTURBANCE 1441 0.0075
126 HEADACHE 4670 0.0074
127 UPPER RESPIRATORY TRACT INFECTION 341 0.0074
128 DYSGRAPHIA 48 0.0073
129 OROPHARYNGEAL PAIN 668 0.0072
130 FATIGUE 5591 0.0072
131 MATERNAL EXPOSURE DURING BREAST FEEDING 29 0.0071
132 INJECTION SITE BRUISING 565 0.0071
133 ORAL HERPES 137 0.0070
134 MICTURITION URGENCY 80 0.0070
135 NASOPHARYNGITIS 1283 0.0070
136 TUNNEL VISION 13 0.0069
137 UPPER RESPIRATORY TRACT CONGESTION 20 0.0069
138 NONINFECTIVE GINGIVITIS 10 0.0069
139 INJECTION SITE DISCOMFORT 72 0.0068
140 DYSPHEMIA 30 0.0068
141 MOVEMENT DISORDER 214 0.0067
142 HEPATITIS B REACTIVATION 21 0.0066
143 LYME DISEASE 22 0.0066
144 BLADDER DISORDER 65 0.0065
145 HYPOKINESIA 95 0.0065
146 CD4 LYMPHOCYTES DECREASED 14 0.0065
147 ENERGY INCREASED 38 0.0064
148 BLADDER SPASM 12 0.0064
149 BACTERIAL VAGINOSIS 10 0.0064
150 BODY TEMPERATURE INCREASED 130 0.0064
151 MOBILITY DECREASED 454 0.0063
152 HEAD DISCOMFORT 110 0.0062
153 CORONAVIRUS INFECTION 41 0.0062
154 SYMPTOM RECURRENCE 37 0.0062
155 NASAL CONGESTION 362 0.0062
156 LYMPHOPENIA 87 0.0061
157 HAEMATOLOGICAL INFECTION 15 0.0061
158 ANAL INCONTINENCE 55 0.0061
159 BLEPHAROSPASM 38 0.0060
160 MIGRAINE 574 0.0060
161 SINUS PAIN 14 0.0060
162 CEREBRAL DISORDER 44 0.0059
163 APHONIA 83 0.0059
164 TONSILLITIS 31 0.0059
165 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 276 0.0059
166 PARAPLEGIA 17 0.0059
167 URINARY TRACT INFECTION 1001 0.0059
168 PAIN 3599 0.0059
169 LAZINESS 10 0.0059
170 SLOW SPEECH 14 0.0058
171 BODY TEMPERATURE FLUCTUATION 12 0.0058
172 FEELING ABNORMAL 1368 0.0057
173 PRODUCT LEAKAGE 32 0.0057
174 DYSSTASIA 166 0.0057
175 FEAR OF INJECTION 40 0.0056
176 DEVICE LEAKAGE 242 0.0056
177 GRIP STRENGTH DECREASED 49 0.0056
178 ECTOPIC PREGNANCY 17 0.0055
179 INVASIVE DUCTAL BREAST CARCINOMA 15 0.0055
180 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 994 0.0055
181 LYMPHOCYTE COUNT INCREASED 18 0.0055
182 PRODUCT STORAGE ERROR 478 0.0055
183 PARAESTHESIA 857 0.0054
184 INJECTION SITE HAEMORRHAGE 429 0.0054
185 ADENOCARCINOMA OF COLON 10 0.0053
186 MYALGIA 906 0.0053
187 LOSS OF CONTROL OF LEGS 20 0.0053
188 HYPOPROTEINAEMIA 10 0.0053
189 IMMUNE SYSTEM DISORDER 69 0.0052
190 INFLUENZA 583 0.0052
191 INFECTION 756 0.0052
192 SLEEP DEFICIT 11 0.0052
193 OROPHARYNGEAL DISCOMFORT 47 0.0052
194 INJECTION SITE EXTRAVASATION 64 0.0052
195 DRUG DOSE OMISSION BY DEVICE 406 0.0052
196 SENSORY DISTURBANCE 83 0.0052
197 PERIPHERAL COLDNESS 71 0.0052
198 MUSCULOSKELETAL DISORDER 98 0.0051
199 EAR PRURITUS 18 0.0051
200 LYMPHOCYTOSIS 11 0.0051
201 MEMORY IMPAIRMENT 702 0.0051
202 INCONTINENCE 54 0.0051
203 COGNITIVE DISORDER 238 0.0051
204 SPINAL STENOSIS 21 0.0051
205 SERUM SICKNESS 14 0.0050
206 DIPLOPIA 129 0.0050
207 EAR INFECTION 132 0.0050
208 SPINAL PAIN 58 0.0049
209 MENINGITIS 33 0.0049
210 MATERNAL EXPOSURE DURING PREGNANCY 437 0.0049
211 ANIMAL BITE 13 0.0049
212 FEELING HOT 299 0.0049
213 HERPES VIRUS INFECTION 28 0.0049
214 VITAMIN B12 DECREASED 14 0.0049
215 SPUTUM DISCOLOURED 46 0.0048
216 NEAR DEATH EXPERIENCE 16 0.0048
217 MUSCLE CONTRACTIONS INVOLUNTARY 17 0.0048
218 FRUSTRATION TOLERANCE DECREASED 39 0.0048
219 PHARYNGEAL SWELLING 47 0.0048
220 PARANASAL SINUS DISCOMFORT 18 0.0048
221 TREMOR 788 0.0047
222 KIDNEY INFECTION 93 0.0047
223 SKIN INFECTION 53 0.0047
224 VERTIGO 281 0.0046
225 SENSITIVE SKIN 34 0.0046
226 SNEEZING 103 0.0046
227 JOINT LOCK 13 0.0046
228 ATAXIA 54 0.0045
229 SUSPECTED COVID-19 15 0.0045
230 PANNICULITIS 11 0.0045
231 ABORTION SPONTANEOUS 182 0.0045
232 HYPERTONIC BLADDER 13 0.0045
233 TEMPERATURE REGULATION DISORDER 10 0.0045
234 VAGINAL INFECTION 21 0.0045
235 WEIGHT BEARING DIFFICULTY 12 0.0045
236 FUNGAL SKIN INFECTION 18 0.0045
237 URINARY INCONTINENCE 132 0.0045
238 MUSCLE SPASMS 817 0.0044
239 COORDINATION ABNORMAL 62 0.0044
240 SENSITIVITY TO WEATHER CHANGE 23 0.0044
241 HERPES ZOSTER 250 0.0043
242 RESPIRATORY TRACT CONGESTION 69 0.0043
243 LICHEN PLANUS 10 0.0043
244 HYPERACUSIS 16 0.0043
245 SPEECH DISORDER 223 0.0043
246 FACIAL PARALYSIS 36 0.0042
247 EAR PAIN 82 0.0042
248 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 21 0.0042
249 TUMOUR LYSIS SYNDROME 37 0.0042
250 POOR QUALITY SLEEP 90 0.0042
251 MUSCULOSKELETAL STIFFNESS 363 0.0041
252 MOTOR DYSFUNCTION 42 0.0041
253 VIRAL INFECTION 137 0.0041
254 PNEUMONIA VIRAL 13 0.0041
255 EAR CONGESTION 11 0.0041
256 PNEUMONIA FUNGAL 16 0.0041
257 LUNG INFECTION 63 0.0041
258 PAIN IN EXTREMITY 1194 0.0040
259 ARTHROPOD BITE 30 0.0040
260 ENCEPHALITIS 28 0.0040
261 ASTHENIA 1520 0.0040
262 ATTENTION DEFICIT HYPERACTIVITY DISORDER 17 0.0040
263 HYPERPYREXIA 17 0.0040
264 HYPERSOMNIA 115 0.0040
265 SINUS CONGESTION 54 0.0040
266 NEUTROPENIA 543 0.0040
267 RESPIRATORY TRACT INFECTION 104 0.0040
268 HEMIPLEGIA 33 0.0040
269 BACK PAIN 921 0.0040
270 LETHARGY 228 0.0040
271 IMMUNODEFICIENCY 59 0.0040
272 HAEMORRHAGE URINARY TRACT 10 0.0039
273 ABDOMINAL INFECTION 10 0.0039
274 CONCUSSION 30 0.0039
275 AGRANULOCYTOSIS 72 0.0039
276 SINUSITIS 397 0.0039
277 VITAMIN D DECREASED 33 0.0039
278 COLD SWEAT 68 0.0039
279 BLOOD CREATININE DECREASED 12 0.0038
280 PRODUCT AVAILABILITY ISSUE 87 0.0038
281 DYSARTHRIA 143 0.0038
282 EYE MOVEMENT DISORDER 26 0.0038
283 NERVE COMPRESSION 35 0.0038
284 ABORTION 11 0.0038
285 GASTROENTERITIS VIRAL 68 0.0038
286 UPPER-AIRWAY COUGH SYNDROME 31 0.0038
287 PRODUCT DISPENSING ISSUE 16 0.0037
288 COVID-19 PNEUMONIA 44 0.0037
289 PHARYNGITIS STREPTOCOCCAL 40 0.0037
290 COUGH 1031 0.0037
291 HEAVY MENSTRUAL BLEEDING 33 0.0037
292 MUSCULOSKELETAL DISCOMFORT 63 0.0037
293 GASTRIC INFECTION 14 0.0037
294 LUNG ADENOCARCINOMA 11 0.0037
295 ASTHENOPIA 20 0.0036
296 NECK PAIN 203 0.0036
297 CHOLECYSTITIS INFECTIVE 10 0.0036
298 VISUAL IMPAIRMENT 446 0.0036
299 STREPTOCOCCAL INFECTION 20 0.0036
300 ORAL INFECTION 14 0.0036
301 INTERVERTEBRAL DISC PROTRUSION 78 0.0036
302 MENINGITIS ASEPTIC 16 0.0036
303 MUSCLE TWITCHING 82 0.0036
304 THROAT IRRITATION 159 0.0035
305 BLINDNESS TRANSIENT 26 0.0035
306 INTERVERTEBRAL DISC DISORDER 15 0.0035
307 NEPHROTIC SYNDROME 24 0.0035
308 TOOTH INFECTION 46 0.0035
309 TENSION HEADACHE 15 0.0035
310 FACIAL PAIN 31 0.0035
311 SEASONAL ALLERGY 49 0.0035
312 APPENDICITIS 32 0.0034
313 RESTLESS LEGS SYNDROME 62 0.0034
314 FACIAL PARESIS 12 0.0034
315 OCULAR DISCOMFORT 38 0.0034
316 COLITIS MICROSCOPIC 16 0.0034
317 INJECTION SITE PAIN 1035 0.0034
318 EYE INFECTION 38 0.0034
319 PRODUCTIVE COUGH 160 0.0033
320 DEPRESSED MOOD 177 0.0033
321 RHINOVIRUS INFECTION 13 0.0033
322 OTITIS MEDIA 11 0.0033
323 ATRIAL FIBRILLATION 324 0.0033
324 PRODUCT DOSE OMISSION IN ERROR 94 0.0033
325 HEPATITIS B 20 0.0033
326 VULVOVAGINAL MYCOTIC INFECTION 13 0.0033
327 DISEASE RECURRENCE 156 0.0033
328 DYSAESTHESIA 10 0.0033
329 PHARYNGITIS 40 0.0032
330 PERFORMANCE STATUS DECREASED 15 0.0032
331 INJECTION SITE INFLAMMATION 16 0.0032
332 BURNING SENSATION 224 0.0032
333 DEVICE ISSUE 285 0.0032
334 SKIN ABRASION 15 0.0032
335 MALAISE 1391 0.0032
336 DEVICE DEPLOYMENT ISSUE 40 0.0031
337 HAEMORRHAGE 325 0.0031
338 NIGHT SWEATS 99 0.0031
339 VISION BLURRED 421 0.0031
340 NAIL DISCOLOURATION 12 0.0030
341 TOOTH ABSCESS 31 0.0030
342 FALL 1012 0.0030
343 SECRETION DISCHARGE 38 0.0030
344 DEVICE DELIVERY SYSTEM ISSUE 83 0.0030
345 MONOCYTE COUNT INCREASED 11 0.0030
346 EAR DISCOMFORT 31 0.0030
347 FORMICATION 21 0.0030
348 NYSTAGMUS 16 0.0030
349 EXPOSURE VIA BREAST MILK 12 0.0030
350 MUSCLE STRAIN 26 0.0030
351 FOOD POISONING 16 0.0030
352 MALIGNANT MELANOMA 40 0.0030
353 SQUAMOUS CELL CARCINOMA OF SKIN 18 0.0030
354 BREAST MASS 20 0.0030
355 GINGIVITIS 16 0.0030
356 APHTHOUS ULCER 23 0.0030
357 VIRAL UPPER RESPIRATORY TRACT INFECTION 14 0.0029
358 B-CELL LYMPHOMA 10 0.0029
359 LIGAMENT RUPTURE 13 0.0029
360 CYTOMEGALOVIRUS INFECTION REACTIVATION 13 0.0029
361 THROMBOCYTOPENIA 328 0.0029
362 MENISCUS INJURY 18 0.0029
363 CYSTITIS 93 0.0029
364 SKIN LESION 80 0.0029
365 APHASIA 88 0.0029
366 LYMPHOEDEMA 20 0.0029
367 SECOND PRIMARY MALIGNANCY 24 0.0029
368 POLYMENORRHOEA 10 0.0029
369 HYPERHIDROSIS 371 0.0029
370 UTERINE LEIOMYOMA 21 0.0029
371 HYPERREFLEXIA 10 0.0029
372 BLOOD THYROID STIMULATING HORMONE DECREASED 13 0.0029
373 URINE ABNORMALITY 13 0.0029
374 PRODUCT ADMINISTRATION ERROR 57 0.0028
375 PHOTOPHOBIA 53 0.0028
376 SUNBURN 21 0.0028
377 PRODUCT ADMINISTRATION INTERRUPTED 22 0.0028
378 AFFECTIVE DISORDER 22 0.0028
379 FUNGAL INFECTION 93 0.0028
380 HYPOAESTHESIA ORAL 42 0.0028
381 BLINDNESS UNILATERAL 39 0.0028
382 PIGMENTATION DISORDER 17 0.0028
383 BLINDNESS 112 0.0027
384 PRODUCT PACKAGING ISSUE 26 0.0027
385 ENDOMETRIOSIS 13 0.0027
386 ENURESIS 11 0.0027
387 VITAMIN B12 DEFICIENCY 11 0.0027
388 DIZZINESS POSTURAL 26 0.0027
389 THROAT CLEARING 10 0.0027
390 DIZZINESS 1328 0.0027
391 PRODUCT DOSE OMISSION ISSUE 782 0.0027
392 GENERAL PHYSICAL CONDITION ABNORMAL 18 0.0027
393 FURUNCLE 21 0.0026
394 AUTOIMMUNE THYROIDITIS 10 0.0026
395 RESPIRATORY SYNCYTIAL VIRUS INFECTION 23 0.0026
396 BRONCHITIS 195 0.0026
397 FACE INJURY 10 0.0026
398 ORGANISING PNEUMONIA 13 0.0026
399 IMMUNE THROMBOCYTOPENIA 12 0.0026
400 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 10 0.0026
401 HERPES SIMPLEX 17 0.0026
402 EXERCISE TOLERANCE DECREASED 15 0.0026
403 THYROID MASS 10 0.0026
404 RHINITIS 21 0.0026
405 YELLOW SKIN 12 0.0026
406 CERVIX CARCINOMA 10 0.0026
407 FEELING DRUNK 19 0.0026
408 EYE DISORDER 84 0.0026
409 URINE ODOUR ABNORMAL 15 0.0025
410 TOOTH INJURY 11 0.0025
411 PHOTOPSIA 16 0.0025
412 MOOD ALTERED 69 0.0025
413 BLOOD IRON DECREASED 30 0.0025
414 MENTAL IMPAIRMENT 61 0.0025
415 POLLAKIURIA 104 0.0025
416 ANOSMIA 36 0.0025
417 EYE PAIN 140 0.0025
418 DEVICE MECHANICAL ISSUE 34 0.0025
419 CONTUSION 238 0.0025
420 INJURY ASSOCIATED WITH DEVICE 50 0.0025
421 SCIATICA 39 0.0024
422 PNEUMONIA 790 0.0024
423 LYMPHADENOPATHY 86 0.0024
424 URINARY RETENTION 81 0.0024
425 LIGAMENT SPRAIN 24 0.0024
426 LOWER LIMB FRACTURE 46 0.0024
427 UROSEPSIS 22 0.0024
428 LIVER FUNCTION TEST INCREASED 51 0.0024
429 SINUS DISORDER 47 0.0024
430 BASAL CELL CARCINOMA 37 0.0024
431 ARTHRALGIA 986 0.0024
432 ROSACEA 11 0.0024
433 SINUS HEADACHE 14 0.0024
434 NEPHROLITHIASIS 108 0.0024
435 GASTROINTESTINAL INFECTION 21 0.0023
436 LIQUID PRODUCT PHYSICAL ISSUE 17 0.0023
437 TEARFULNESS 10 0.0023
438 DISEASE PROGRESSION 274 0.0023
439 NAUSEA 1832 0.0023
440 INJECTION SITE VESICLES 14 0.0023
441 HORDEOLUM 10 0.0023
442 PYELONEPHRITIS 20 0.0023
443 THINKING ABNORMAL 43 0.0023
444 BACK INJURY 25 0.0023
445 MENSTRUAL DISORDER 19 0.0023
446 BRAIN NEOPLASM 21 0.0023
447 MOUTH ULCERATION 48 0.0023
448 SCRATCH 24 0.0023
449 CHEST DISCOMFORT 232 0.0023
450 PERSONALITY CHANGE 21 0.0023
451 ILL-DEFINED DISORDER 137 0.0023
452 BACTERIAL INFECTION 42 0.0022
453 NERVOUSNESS 117 0.0022
454 POST-TRAUMATIC STRESS DISORDER 15 0.0022
455 VITREOUS FLOATERS 22 0.0022
456 BONE PAIN 131 0.0022
457 TASTE DISORDER 45 0.0022
458 PSEUDOMONAS INFECTION 19 0.0022
459 FOOT FRACTURE 42 0.0022
460 VISUAL FIELD DEFECT 16 0.0022
461 INFLAMMATION 114 0.0022
462 ORAL CANDIDIASIS 29 0.0022
463 BRADYKINESIA 13 0.0022
464 SLEEP DISORDER 155 0.0022
465 INJECTION SITE PRURITUS 147 0.0022
466 HYPERAESTHESIA 18 0.0022
467 ERYSIPELAS 11 0.0022
468 ADVERSE REACTION 29 0.0022
469 CHOLECYSTITIS 26 0.0022
470 PNEUMONIA BACTERIAL 20 0.0022
471 DEAFNESS UNILATERAL 12 0.0022
472 ACCIDENT 26 0.0022
473 DYSPHONIA 127 0.0022
474 CYTOMEGALOVIRUS INFECTION 36 0.0022
475 INJECTION SITE REACTION 149 0.0022
476 SOMNOLENCE 436 0.0022
477 DRY THROAT 22 0.0022
478 AUTOIMMUNE DISORDER 21 0.0022
479 JOINT INJURY 46 0.0022
480 ALOPECIA 422 0.0021
481 EMOTIONAL DISORDER 66 0.0021
482 PANIC ATTACK 78 0.0021
483 DISCOMFORT 130 0.0021
484 PAPULE 15 0.0021
485 AGEUSIA 53 0.0021
486 INSOMNIA 565 0.0021
487 AMNESIA 138 0.0021
488 TENDERNESS 22 0.0021
489 NEUROLOGICAL SYMPTOM 12 0.0021
490 MUSCLE DISORDER 17 0.0021
491 SKIN MASS 14 0.0021
492 JOINT STIFFNESS 55 0.0021
493 DEVICE PHYSICAL PROPERTY ISSUE 16 0.0021
494 SUBCUTANEOUS ABSCESS 10 0.0021
495 COLITIS 79 0.0021
496 EPSTEIN-BARR VIRUS INFECTION 13 0.0021
497 DIFFUSE LARGE B-CELL LYMPHOMA 16 0.0021
498 HOT FLUSH 156 0.0021
499 SEIZURE 239 0.0021
500 TENDONITIS 32 0.0021
501 HORMONE LEVEL ABNORMAL 10 0.0020
502 CYTOKINE RELEASE SYNDROME 41 0.0020
503 WHITE BLOOD CELL COUNT ABNORMAL 13 0.0020
504 ABDOMINAL ABSCESS 9 0.0020
505 GLUCOSE TOLERANCE IMPAIRED 12 0.0020
506 FLANK PAIN 19 0.0020
507 HYPERSENSITIVITY 375 0.0020
508 GINGIVAL PAIN 16 0.0020
509 INJECTION SITE DISCOLOURATION 25 0.0020
510 HEAD INJURY 63 0.0020
511 VOMITING 934 0.0020
512 DYSURIA 73 0.0020
513 HEART RATE ABNORMAL 11 0.0020
514 ANAEMIA 376 0.0020
515 INTERMENSTRUAL BLEEDING 11 0.0020
516 INJECTION SITE IRRITATION 25 0.0020
517 DEVICE USE ISSUE 34 0.0019
518 PARAESTHESIA ORAL 28 0.0019
519 PERIPHERAL SWELLING 299 0.0019
520 GAMMA-GLUTAMYLTRANSFERASE INCREASED 43 0.0019
521 SCOLIOSIS 12 0.0019
522 FAILURE TO THRIVE 10 0.0019
523 CELLULITIS 96 0.0019
524 SEPSIS 212 0.0019
525 CONDITION AGGRAVATED 576 0.0019
526 PNEUMOCYSTIS JIROVECII PNEUMONIA 19 0.0019
527 DISTURBANCE IN ATTENTION 102 0.0019
528 RENAL PAIN 20 0.0019
529 MUSCULOSKELETAL CHEST PAIN 29 0.0019
530 CRYING 68 0.0019
531 HYPERCALCAEMIA 23 0.0019
532 EXTRASYSTOLES 13 0.0019
533 INJECTION SITE RASH 57 0.0019
534 ANAL ABSCESS 10 0.0019
535 PLEURISY 11 0.0019
536 PRESYNCOPE 45 0.0018
537 GASTROENTERITIS 27 0.0018
538 MUSCLE RIGIDITY 22 0.0018
539 INTERVERTEBRAL DISC DEGENERATION 17 0.0018
540 HEART RATE INCREASED 182 0.0018
541 CONJUNCTIVITIS 34 0.0018
542 POISONING 23 0.0018
543 FLUSHING 186 0.0018
544 TOOTHACHE 33 0.0018
545 NONSPECIFIC REACTION 10 0.0018
546 SPINAL OSTEOARTHRITIS 16 0.0018
547 SYNCOPE 182 0.0018
548 HAEMOLYSIS 14 0.0018
549 INJECTION SITE MASS 67 0.0018
550 SQUAMOUS CELL CARCINOMA 17 0.0018
551 INJECTION SITE INJURY 10 0.0018
552 CHOKING 35 0.0018
553 THIRST 32 0.0018
554 INJECTION SITE ERYTHEMA 222 0.0018
555 CARPAL TUNNEL SYNDROME 25 0.0018
556 EATING DISORDER 38 0.0018
557 MACULAR OEDEMA 10 0.0018
558 INJECTION SITE SWELLING 136 0.0018
559 SKIN CANCER 38 0.0018
560 LOSS OF CONSCIOUSNESS 225 0.0018
561 DYSKINESIA 71 0.0017
562 PULMONARY CONGESTION 23 0.0017
563 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 13 0.0017
564 NOCTURIA 21 0.0017
565 SPLENOMEGALY 20 0.0017
566 URTICARIA 286 0.0017
567 BOWEL MOVEMENT IRREGULARITY 13 0.0017
568 PREMATURE DELIVERY 27 0.0017
569 LOCALISED INFECTION 41 0.0017
570 HAND FRACTURE 12 0.0017
571 LIMB INJURY 46 0.0017
572 ABDOMINAL DISCOMFORT 284 0.0017
573 HEPATIC ENZYME INCREASED 115 0.0017
574 STATUS EPILEPTICUS 19 0.0017
575 HAEMOLYTIC ANAEMIA 15 0.0017
576 AFFECT LABILITY 16 0.0017
577 CANDIDA INFECTION 28 0.0017
578 MENTAL DISORDER 72 0.0017
579 DYSPHAGIA 156 0.0016
580 VITAMIN D DEFICIENCY 16 0.0016
581 BLOOD ALBUMIN DECREASED 13 0.0016
582 RESPIRATORY DISORDER 49 0.0016
583 LARYNGEAL OEDEMA 10 0.0016
584 PALPITATIONS 189 0.0016
585 MATERNAL EXPOSURE BEFORE PREGNANCY 11 0.0016
586 BRAIN INJURY 16 0.0016
587 WRIST FRACTURE 19 0.0016
588 HICCUPS 13 0.0016
589 ADVERSE DRUG REACTION 142 0.0016
590 EYE INFLAMMATION 15 0.0016
591 MYOCARDITIS 18 0.0016
592 LEUKOPENIA 78 0.0016
593 ROAD TRAFFIC ACCIDENT 65 0.0016
594 ANKLE FRACTURE 24 0.0015
595 THERMAL BURN 11 0.0015
596 UVEITIS 21 0.0015
597 BRONCHOPULMONARY ASPERGILLOSIS 12 0.0015
598 CARDIAC FLUTTER 10 0.0015
599 GLOMERULAR FILTRATION RATE DECREASED 19 0.0015
600 DEPRESSION 351 0.0015
601 ANXIETY 439 0.0015
602 NERVE INJURY 17 0.0015
603 BLOOD URINE PRESENT 29 0.0015
604 INCORRECT DOSE ADMINISTERED 348 0.0015
605 PANIC REACTION 11 0.0015
606 IMPAIRED HEALING 50 0.0015
607 SWELLING FACE 99 0.0015
608 SLEEP APNOEA SYNDROME 29 0.0015
609 PHOTOSENSITIVITY REACTION 25 0.0015
610 INJECTION SITE URTICARIA 37 0.0015
611 EXPOSURE VIA SKIN CONTACT 39 0.0015
612 SWOLLEN TONGUE 47 0.0015
613 RETCHING 32 0.0015
614 DIVERTICULITIS 41 0.0015
615 SPINAL DISORDER 14 0.0015
616 MENSTRUATION DELAYED 16 0.0015
617 WHITE BLOOD CELL COUNT DECREASED 160 0.0015
618 INTENTIONAL DOSE OMISSION 42 0.0015
619 DECUBITUS ULCER 12 0.0015
620 INITIAL INSOMNIA 15 0.0015
621 TOOTH FRACTURE 16 0.0014
622 PAIN OF SKIN 39 0.0014
623 THERAPY NON-RESPONDER 65 0.0014
624 EMBOLISM 12 0.0014
625 CHEST PAIN 267 0.0014
626 NEUROPATHY PERIPHERAL 136 0.0014
627 THYROID DISORDER 22 0.0014
628 BREAST CANCER 133 0.0014
629 BLOOD TEST ABNORMAL 20 0.0014
630 BLOOD CALCIUM DECREASED 16 0.0014
631 MENSTRUATION IRREGULAR 38 0.0014
632 BLOOD PRESSURE ABNORMAL 28 0.0014
633 WHITE BLOOD CELL COUNT INCREASED 54 0.0014
634 GASTROINTESTINAL DISORDER 126 0.0014
635 HYPOTONIA 14 0.0014
636 LOW BIRTH WEIGHT BABY 11 0.0014
637 BIPOLAR DISORDER 15 0.0014
638 ABSCESS 22 0.0014
639 BRADYPHRENIA 9 0.0014
640 CLOSTRIDIUM DIFFICILE INFECTION 30 0.0014
641 TINNITUS 63 0.0014
642 RASH 597 0.0014
643 MYASTHENIA GRAVIS 11 0.0014
644 ARTHRITIS 107 0.0014
645 MASS 19 0.0014
646 PRURITUS 522 0.0014
647 APPETITE DISORDER 9 0.0014
648 RASH MACULAR 47 0.0013
649 FEAR 36 0.0013
650 NEPHROPATHY TOXIC 15 0.0013
651 CHROMATURIA 30 0.0013
652 SWELLING 124 0.0013
653 WEIGHT INCREASED 295 0.0013
654 THERAPEUTIC PRODUCT EFFECT DECREASED 59 0.0013
655 PRODUCT PREPARATION ERROR 27 0.0013
656 GENERAL PHYSICAL HEALTH DETERIORATION 152 0.0013
657 INJECTION SITE WARMTH 27 0.0013
658 HYPERTHERMIA 10 0.0013
659 PLATELET COUNT INCREASED 17 0.0013
660 ALANINE AMINOTRANSFERASE INCREASED 80 0.0013
661 APATHY 19 0.0013
662 OVARIAN CYST 13 0.0013
663 BLISTER 73 0.0013
664 DECREASED ACTIVITY 14 0.0013
665 INFUSION RELATED REACTION 86 0.0013
666 FOOD ALLERGY 10 0.0013
667 THROAT TIGHTNESS 35 0.0013
668 HUNGER 18 0.0013
669 MOOD SWINGS 41 0.0013
670 FIBROMYALGIA 31 0.0013
671 CONFUSIONAL STATE 206 0.0013
672 CYANOSIS 20 0.0013
673 SEPTIC SHOCK 55 0.0013
674 FOOT DEFORMITY 14 0.0013
675 IRRITABLE BOWEL SYNDROME 27 0.0013
676 INCREASED APPETITE 24 0.0013
677 GROIN PAIN 11 0.0013
678 ORAL PAIN 28 0.0012
679 THYROID CANCER 15 0.0012
680 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 42 0.0012
681 FEEDING DISORDER 25 0.0012
682 ANAPHYLACTIC REACTION 68 0.0012
683 POST PROCEDURAL INFECTION 10 0.0012
684 NEUTROPHIL COUNT DECREASED 50 0.0012
685 ANGER 41 0.0012
686 EPILEPSY 37 0.0012
687 ABDOMINAL PAIN UPPER 247 0.0012
688 DECREASED APPETITE 278 0.0012
689 SKIN LACERATION 13 0.0012
690 WEIGHT DECREASED 331 0.0012
691 DEAFNESS 31 0.0012
692 BACTERAEMIA 14 0.0012
693 MYELODYSPLASTIC SYNDROME 17 0.0012
694 ANAPHYLACTIC SHOCK 30 0.0012
695 THERAPY INTERRUPTED 83 0.0012
696 UPPER LIMB FRACTURE 23 0.0012
697 C-REACTIVE PROTEIN INCREASED 42 0.0012
698 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 82 0.0012
699 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
700 RESTLESSNESS 42 0.0011
701 JOINT DISLOCATION 12 0.0011
702 SKIN DISCOLOURATION 52 0.0011
703 NEOPLASM 13 0.0011
704 OSTEOPENIA 17 0.0011
705 RIB FRACTURE 23 0.0011
706 BLOOD SODIUM DECREASED 21 0.0011
707 PULMONARY THROMBOSIS 12 0.0011
708 GINGIVAL BLEEDING 15 0.0011
709 ACUTE CORONARY SYNDROME 9 0.0011
710 DISORIENTATION 43 0.0011
711 FOETAL EXPOSURE DURING PREGNANCY 88 0.0011
712 SKIN DISORDER 36 0.0011
713 DYSPNOEA 608 0.0011
714 PNEUMONITIS 29 0.0011
715 SKIN REACTION 15 0.0011
716 REBOUND EFFECT 12 0.0011
717 PAIN IN JAW 30 0.0011
718 DYSMENORRHOEA 14 0.0011
719 DRUG INTOLERANCE 102 0.0011
720 ASPARTATE AMINOTRANSFERASE INCREASED 56 0.0011
721 BRONCHOSPASM 15 0.0011
722 DEVICE FAILURE 16 0.0010
723 FEELING JITTERY 20 0.0010
724 OSTEOMYELITIS 19 0.0010
725 EYE SWELLING 39 0.0010
726 THERAPEUTIC RESPONSE UNEXPECTED 47 0.0010
727 BACK DISORDER 17 0.0010
728 QUALITY OF LIFE DECREASED 14 0.0010
729 GLAUCOMA 20 0.0010
730 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 19 0.0010
731 TACHYCARDIA 92 0.0010
732 DRY MOUTH 84 0.0010
733 IMPAIRED GASTRIC EMPTYING 14 0.0010
734 HEPATIC STEATOSIS 19 0.0010
735 PRODUCT USE COMPLAINT 16 0.0010
736 IRRITABILITY 60 0.0010
737 DENTAL CARIES 11 0.0010
738 SCAR 17 0.0010
739 HYPOTHERMIA 10 0.0010
740 RASH PRURITIC 53 0.0010
741 HYPOACUSIS 42 0.0010
742 HELICOBACTER INFECTION 10 0.0010
743 LIVER FUNCTION TEST ABNORMAL 28 0.0010
744 THERAPY PARTIAL RESPONDER 15 0.0010
745 LACRIMATION INCREASED 29 0.0010
746 NEOPLASM MALIGNANT 64 0.0010
747 PALLOR 26 0.0010
748 DIARRHOEA 616 0.0010
749 DERMATITIS ALLERGIC 12 0.0010
750 FOLLICULITIS 10 0.0010
751 DRUG INEFFECTIVE 1250 0.0009
752 MUSCLE ATROPHY 12 0.0009
753 DIABETES MELLITUS 72 0.0009
754 CIRCULATORY COLLAPSE 16 0.0009
755 CONSTIPATION 203 0.0009
756 NERVOUS SYSTEM DISORDER 29 0.0009
757 DEVICE DIFFICULT TO USE 61 0.0009
758 PRODUCT DISPENSING ERROR 20 0.0009
759 ERYTHEMA 188 0.0009
760 BODY TEMPERATURE DECREASED 9 0.0009
761 GASTROINTESTINAL PAIN 10 0.0009
762 BURSITIS 11 0.0009
763 HYPOPHAGIA 23 0.0009
764 BLOOD POTASSIUM DECREASED 27 0.0009
765 HAIR TEXTURE ABNORMAL 12 0.0009
766 DEVICE USE ERROR 31 0.0009
767 JOINT SWELLING 107 0.0009
768 CYST 11 0.0009
769 DERMATITIS CONTACT 10 0.0009
770 PULMONARY MASS 13 0.0009
771 ABDOMINAL PAIN LOWER 22 0.0009
772 DEHYDRATION 116 0.0009
773 PREMATURE BABY 26 0.0009
774 ORAL DISCOMFORT 12 0.0009
775 PULMONARY EMBOLISM 82 0.0009
776 DRY EYE 43 0.0009
777 ECZEMA 45 0.0009
778 ABDOMINAL PAIN 200 0.0009
779 WOUND 24 0.0009
780 SINUS TACHYCARDIA 12 0.0008
781 WHEEZING 50 0.0008
782 LYMPHOMA 13 0.0008
783 ALTERED STATE OF CONSCIOUSNESS 18 0.0008
784 HYPERTHYROIDISM 12 0.0008
785 LABORATORY TEST ABNORMAL 24 0.0008
786 LIVER DISORDER 36 0.0008
787 SKIN HAEMORRHAGE 12 0.0008
788 HYPOKALAEMIA 37 0.0008
789 HEART RATE DECREASED 28 0.0008
790 HEPATIC FAILURE 24 0.0008
791 BLOOD CHOLESTEROL INCREASED 37 0.0008
792 BRAIN OEDEMA 10 0.0008
793 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 160 0.0008
794 DEVICE BREAKAGE 32 0.0008
795 CARDIOVASCULAR DISORDER 20 0.0008
796 HYPOTHYROIDISM 25 0.0008
797 HEPATITIS 20 0.0008
798 JAUNDICE 21 0.0008
799 PRODUCT PRESCRIBING ISSUE 17 0.0008
800 ACNE 59 0.0008
801 MULTIPLE ORGAN DYSFUNCTION SYNDROME 22 0.0008
802 LIVER INJURY 19 0.0008
803 RED BLOOD CELL COUNT DECREASED 22 0.0008
804 DYSGEUSIA 57 0.0008
805 HYPERTENSION 162 0.0008
806 RASH MACULO-PAPULAR 17 0.0008
807 GLOSSODYNIA 17 0.0008
808 THERAPEUTIC RESPONSE DECREASED 46 0.0008
809 PNEUMOTHORAX 12 0.0008
810 OBESITY 12 0.0008
811 HEART RATE IRREGULAR 17 0.0008
812 EYE HAEMORRHAGE 10 0.0007
813 SPINAL FRACTURE 15 0.0007
814 JOINT RANGE OF MOTION DECREASED 10 0.0007
815 POST PROCEDURAL COMPLICATION 14 0.0007
816 BLOOD PRESSURE INCREASED 111 0.0007
817 SKIN BURNING SENSATION 52 0.0007
818 ASTHMA 82 0.0007
819 STOMATITIS 44 0.0007
820 PERITONITIS 15 0.0007
821 DYSTONIA 14 0.0007
822 HAEMORRHOIDS 14 0.0007
823 EYE PRURITUS 24 0.0007
824 PRODUCT COMPLAINT 18 0.0007
825 CEREBROVASCULAR ACCIDENT 120 0.0007
826 ACUTE MYELOID LEUKAEMIA 11 0.0007
827 BLOOD GLUCOSE ABNORMAL 13 0.0007
828 CHOLELITHIASIS 23 0.0007
829 FULL BLOOD COUNT DECREASED 14 0.0007
830 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
831 PRODUCT USE ISSUE 130 0.0007
832 DELIRIUM 24 0.0007
833 ULCER 11 0.0007
834 VAGINAL HAEMORRHAGE 30 0.0007
835 LIP SWELLING 23 0.0007
836 BLOOD ALKALINE PHOSPHATASE INCREASED 17 0.0007
837 HIP FRACTURE 22 0.0007
838 GASTRIC ULCER 13 0.0007
839 THROMBOSIS 55 0.0007
840 OEDEMA 37 0.0007
841 TRANSIENT ISCHAEMIC ATTACK 23 0.0007
842 ERUCTATION 13 0.0007
843 RASH PAPULAR 15 0.0007
844 GOUT 12 0.0007
845 DERMATITIS 14 0.0007
846 HYPOTENSION 133 0.0007
847 VISUAL ACUITY REDUCED 22 0.0007
848 PERICARDITIS 11 0.0007
849 INSURANCE ISSUE 10 0.0007
850 TREATMENT FAILURE 54 0.0007
851 ABDOMINAL DISTENSION 68 0.0007
852 HAEMOPTYSIS 18 0.0006
853 RESPIRATORY FAILURE 47 0.0006
854 ACUTE MYOCARDIAL INFARCTION 19 0.0006
855 DYSPEPSIA 63 0.0006
856 PARANOIA 11 0.0006
857 STAPHYLOCOCCAL INFECTION 21 0.0006
858 PSORIASIS 83 0.0006
859 TOOTH DISORDER 14 0.0006
860 RASH ERYTHEMATOUS 30 0.0006
861 PANCYTOPENIA 35 0.0006
862 METASTASES TO LIVER 11 0.0006
863 BLOOD PRESSURE FLUCTUATION 15 0.0006
864 HEPATIC FUNCTION ABNORMAL 23 0.0006
865 CATARACT 36 0.0006
866 COLITIS ULCERATIVE 27 0.0006
867 BLOOD PRESSURE DECREASED 40 0.0006
868 PRESCRIBED UNDERDOSE 12 0.0006
869 PNEUMONIA ASPIRATION 15 0.0006
870 HYPOXIA 21 0.0006
871 ANGINA PECTORIS 17 0.0006
872 BLOOD BILIRUBIN INCREASED 16 0.0006
873 MIDDLE INSOMNIA 11 0.0006
874 TRANSAMINASES INCREASED 13 0.0006
875 THERAPY CESSATION 30 0.0006
876 ERECTILE DYSFUNCTION 15 0.0006
877 HAEMATURIA 20 0.0006
878 PLEURAL EFFUSION 35 0.0006
879 CHOLESTASIS 11 0.0006
880 DEMENTIA 16 0.0006
881 AMENORRHOEA 10 0.0006
882 SKIN EXFOLIATION 48 0.0006
883 SKIN FISSURES 11 0.0006
884 GALLBLADDER DISORDER 10 0.0006
885 HALLUCINATION 42 0.0006
886 BONE DISORDER 10 0.0005
887 OCULAR HYPERAEMIA 26 0.0005
888 ABNORMAL DREAMS 15 0.0005
889 SKIN ULCER 14 0.0005
890 RENAL DISORDER 25 0.0005
891 GASTRITIS 14 0.0005
892 DYSPNOEA EXERTIONAL 20 0.0005
893 LUNG DISORDER 26 0.0005
894 MYOCARDIAL INFARCTION 91 0.0005
895 EPISTAXIS 39 0.0005
896 RENAL FAILURE ACUTE 22 0.0005
897 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 27 0.0005
898 HERNIA 10 0.0005
899 EMOTIONAL DISTRESS 62 0.0005
900 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
901 INCORRECT PRODUCT ADMINISTRATION DURATION 11 0.0005
902 HAEMATOCHEZIA 28 0.0005
903 SYSTEMIC LUPUS ERYTHEMATOSUS 18 0.0005
904 DRUG RESISTANCE 13 0.0005
905 PRODUCT PRESCRIBING ERROR 12 0.0005
906 BLOOD GLUCOSE DECREASED 24 0.0005
907 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 24 0.0005
908 PRODUCT PHYSICAL ISSUE 10 0.0005
909 CONTRAINDICATED PRODUCT ADMINISTERED 15 0.0005
910 OSTEOARTHRITIS 21 0.0005
911 PSORIATIC ARTHROPATHY 20 0.0005
912 FLUID RETENTION 25 0.0005
913 NIGHTMARE 17 0.0005
914 OSTEOPOROSIS 20 0.0005
915 DRUG-INDUCED LIVER INJURY 15 0.0005
916 INTESTINAL OBSTRUCTION 18 0.0005
917 DEEP VEIN THROMBOSIS 31 0.0005
918 RESPIRATORY DISTRESS 13 0.0005
919 OXYGEN SATURATION DECREASED 26 0.0005
920 SUICIDAL IDEATION 42 0.0005
921 MUCOSAL INFLAMMATION 12 0.0005
922 OSTEONECROSIS 15 0.0005
923 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
924 ANGIOEDEMA 20 0.0005
925 PRODUCT USE IN UNAPPROVED INDICATION 112 0.0005
926 ARTHROPATHY 25 0.0004
927 DRY SKIN 60 0.0004
928 MALIGNANT NEOPLASM PROGRESSION 46 0.0004
929 CARDIAC DISORDER 42 0.0004
930 PANCREATITIS ACUTE 10 0.0004
931 FREQUENT BOWEL MOVEMENTS 12 0.0004
932 HYPERGLYCAEMIA 16 0.0004
933 SHOCK 10 0.0004
934 ADVERSE EVENT 40 0.0004
935 PLATELET COUNT DECREASED 46 0.0004
936 AGITATION 31 0.0004
937 MUSCULOSKELETAL PAIN 22 0.0004
938 CEREBRAL HAEMORRHAGE 15 0.0004
939 PANCREATITIS 22 0.0004
940 LUNG NEOPLASM MALIGNANT 17 0.0004
941 BLOOD CREATININE INCREASED 27 0.0004
942 HYPONATRAEMIA 23 0.0004
943 INJURY 28 0.0004
944 GASTROOESOPHAGEAL REFLUX DISEASE 32 0.0004
945 TYPE 2 DIABETES MELLITUS 13 0.0004
946 HAEMATOMA 10 0.0004
947 INTERSTITIAL LUNG DISEASE 18 0.0004
948 SKIN IRRITATION 17 0.0004
949 FLATULENCE 21 0.0004
950 OEDEMA PERIPHERAL 45 0.0004
951 RENAL IMPAIRMENT 30 0.0004
952 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 19 0.0003
953 DEATH 298 0.0003
954 ASCITES 10 0.0003
955 PULMONARY OEDEMA 15 0.0003
956 RHEUMATOID ARTHRITIS 38 0.0003
957 OFF LABEL USE 293 0.0003
958 HAEMOGLOBIN DECREASED 34 0.0003
959 EXPIRED PRODUCT ADMINISTERED 11 0.0003
960 FEMUR FRACTURE 10 0.0003
961 GASTRIC DISORDER 11 0.0003
962 CARDIAC ARREST 26 0.0003
963 RENAL FAILURE 41 0.0003
964 ABNORMAL BEHAVIOUR 12 0.0003
965 HOSPITALISATION 46 0.0003
966 CARDIAC FAILURE 24 0.0003
967 UNEVALUABLE EVENT 22 0.0003
968 MEDICATION ERROR 16 0.0003
969 BLOOD GLUCOSE INCREASED 54 0.0003
970 EXTRA DOSE ADMINISTERED 11 0.0003
971 BRADYCARDIA 14 0.0003
972 ARRHYTHMIA 12 0.0003
973 RECTAL HAEMORRHAGE 10 0.0002
974 DERMATITIS ATOPIC 12 0.0002
975 HYPOGLYCAEMIA 11 0.0002
976 EYE IRRITATION 13 0.0002
977 EXPOSURE DURING PREGNANCY 14 0.0002
978 PROSTATE CANCER 18 0.0002
979 AGGRESSION 11 0.0002
980 GASTROINTESTINAL HAEMORRHAGE 18 0.0002
981 SUICIDE ATTEMPT 12 0.0002
982 INTENTIONAL PRODUCT USE ISSUE 16 0.0002
983 DRUG INTERACTION 28 0.0002
984 ACUTE KIDNEY INJURY 27 0.0002
985 PRODUCT QUALITY ISSUE 22 0.0002
986 TOXICITY TO VARIOUS AGENTS 24 0.0001
987 NO ADVERSE EVENT 20 0.0001
988 OVERDOSE 19 0.0001